Status:
COMPLETED
Validation of Patient Reported Outcome Measures for Use in Vulvodynia
Lead Sponsor:
Ipsen
Conditions:
Vulvodynia
Eligibility:
FEMALE
18-45 years
Brief Summary
The overall aim of this project is to demonstrate content validity and usability of the modified Vulvar Pain Assessment Questionnaire (mVPAQ), the modified Female Sexual Function Index (mFSFI), and pa...
Eligibility Criteria
Inclusion
- Fluent in understanding, speaking and reading US-English
- Have vulvodynia with pain for at least 6 months
Exclusion
- Clinically significant history of alcohol/drug abuse or dependence within the last 2 years
Key Trial Info
Start Date :
February 18 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 19 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03770169
Start Date
February 18 2019
End Date
September 19 2019
Last Update
October 28 2019
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
San Diego Sexual Medicine
San Diego, California, United States, 92120
2
Center for Vulvovaginal Disorders
Washington D.C., District of Columbia, United States, 20037
3
Omaha OB-GYN Associates, PC
Omaha, Nebraska, United States, 68130
4
The Center for Vulvovaginal Disorders
New York, New York, United States, 10036